Page last updated: 2024-08-18

pyrroles and phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2

pyrroles has been researched along with phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arencibia, JM; Halmos, G; Koppan, M; Nagy, A; Plonowski, A; Schally, AV1
Halmos, G; Kiaris, H; Nagy, A; Schally, AV; Sun, B; Szepeshazi, K1
Halmos, G; Nagy, A; Plonowski, A; Schally, AV; Sun, B1
Comaru-Schally, AM; Halmos, G; Irimpen, A; Nagy, A; Schally, AV1
Halmos, G; Letsch, M; Nagy, A; Schally, AV; Szepeshazi, K1

Other Studies

5 other study(ies) available for pyrroles and phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2

ArticleYear
Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses.
    Cancer research, 1998, Sep-15, Volume: 58, Issue:18

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Screening Assays, Antitumor; Male; Octreotide; Prostatic Neoplasms; Pyrroles; Rats; Receptors, Somatostatin; Tumor Cells, Cultured

1998
Regression of U-87 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-238.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Cell Survival; Doxorubicin; Glioblastoma; Humans; Male; Mice; Mice, Nude; Octreotide; Pyrroles; Transfection; Tumor Cells, Cultured

2000
Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238.
    International journal of oncology, 2002, Volume: 20, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cytotoxins; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Octreotide; Prostatic Neoplasms; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Treatment Outcome; Tumor Cells, Cultured

2002
Absence of binding of targeted analogs of somatostatin carrying cytotoxic radicals or radionuclides to growth hormone secretagogue receptors on human myocardium.
    Life sciences, 2003, Apr-25, Volume: 72, Issue:23

    Topics: 2-Hydroxyphenethylamine; Aged; Aniline Compounds; Doxorubicin; Humans; Indium Radioisotopes; Male; Middle Aged; Myocardium; Octreotide; Pyrroles; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Ghrelin; Somatostatin

2003
Effective treatment of experimental androgen sensitive and androgen independent intraosseous prostate cancer with targeted cytotoxic somatostatin analogue AN-238.
    The Journal of urology, 2004, Volume: 171, Issue:2 Pt 1

    Topics: Androgens; Animals; Bone Neoplasms; Cell Line, Tumor; Cytotoxins; Doxorubicin; Drug Carriers; Humans; Male; Mice; Mice, Nude; Octreotide; Prostatic Neoplasms; Pyrroles; Somatostatin

2004